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Abstract: COVID-19 coronavirus infection, despite its high contagiousness and rapid spread, is not accompanied 
by the development of the disease in most infected people. The main cause of clinical manifestations of this 
infection is inflammation of the lung tissue, which affects the same parts of the organ as bacterial forms of 
pneumonia, accompanied by identical functional disorders. Functional disorders are caused by inflammatory 
transformation of tissues, not by the pathogen itself, and are manifested not so much in lung ventilation as in the 
effect through the pulmonary vessels on the blood circulation of the entire body. Most patients actually cope with 
the disease on their own, as there are no effective treatment methods yet. However, when the disease has a rapid 
and progressive course, pathogenetic methods are needed to really help patients, which can help the body adapt 
and avoid critical situations. 
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Review Discussion 
       The COVID-19 pandemic has disrupted the 
usual rhythm of our lives, becoming a surprise, a 
serious problem and a great challenge for all 
segments of society, but the prospects for 
overcoming this situation and returning to previous 
social standards remain unclear. Cautious and 
uncertain forecasts of specialists even for the near 
future and daily updates in the media of the number 
of infected and dead sow a sense of anxiety, and 
medical confessions about the lack of effective 
treatment create a sense of insecurity. 
       Suddenly, a complex epidemic and clinical 
situation has emerged, in which many non-standard 
patients have appeared, and the aggregate of 
opinions about their treatment is reduced to the 
conclusion that there are no specific medical 
measures, as well as expectations and hopes for the 
development and production of effective antiviral 
drugs. Meanwhile, treatment of patients with 
coronavirus is currently limited to symptomatic and 
auxiliary means. This passive-expectant attitude has 
its own deep reasons and, in my opinion, does not 
stand up to criticism if we rely on well-known facts. 
       Today we know that the severity and danger of 
coronavirus infection is primarily due to the 
development of acute inflammation in the lungs, and 
the localization and pathological nature of the lesion 
[1,2] correspond to the standard nosology, which is 
known in medicine as acute pneumonia (AP) for 
more than two and a half millennia [3]. Although 
there is a new terminology "COVID-19 pneumonia" 
[4], but in fact, the pandemic did not bring any new 
disease. Inflammatory damage to a particular 
structure, regardless of the pathogen, is inevitably 
accompanied by a violation of its unique function. 
This is an axiom of life of biological objects and 
medicine.  For example, if there is an inflammation of 
the eye, it will be accompanied by visual impairment, 
but not hearing loss, right? 
       Of the five classic signs of inflammation, it is the 
violation of the function of the affected organ that 
determines the features of the pathogenesis and 
clinic of each disease. However, ideas about the 
nature of AP have been significantly distorted over 
the past few decades under the hypnotic influence of 
antibiotic use. The result is a narrow view on the 
decisive role of the pathogen in all aspects of the 
development and course of AP and learned the main 
focus of therapeutic efforts to suppress microbial 
factor. 
       Such narrow principles of AP treatment are 
deeply ingrained in the theory and practice of 
medical training. A number of important facts that 
MINI REVIEW 
MedNEXT J Med Health Sci 1(1) (2020) 1-7 
 
 Vol 1 Iss 1 Year 2020                               Igor Klepikov /2020           
   
Page 2 of 7 
characterize the characteristics of antibiotics and 
stable traditions of their use do not receive due 
attention. For example, it is well known that 
antibiotics have only an antimicrobial effect and do 
not directly affect the inflammatory process and the 
cascade of disorders occurring in the body. Or, for 
example, the use of one type of antibiotics as the 
main (!) treatment not only for AP, but also for many 
incomparable inflammatory diseases should have 
attracted the attention of specialists long ago due to 
its illogical nature from the point of view of clinical 
medicine. 
       The old widespread principle of treating AP, 
which was called "antibiotics alone", has lost its 
broad independence in recent years, and the number 
of patients requiring additional care has steadily 
increased. As a result, experts began to recognize 
such undoubted facts as the validity of the empirical 
use of antibiotics (although this choice prevailed from 
the moment of their appearance), the lack of reliable 
information about the pathogen of AP in most 
treated patients, the futility of attempts to determine 
the pathogen, which do not affect the result of 
treatment in any way [5, 6]. 
       However, such admissions and the lack of 
objective data on the causative agents of AP do not 
mean a change in views on the role and place of 
antibiotics in medical care. These drugs continue to 
be considered as the basis of treatment, and a wide 
range of known pathogens of AP allows us to declare 
the special virulence of microbes in the event of 
treatment failure. In addition, the formation of the 
"microbial" concept of AP has led in recent years to 
the fact that bacterial forms of AP that do not have 
such obvious signs of infectious diseases as 
contagion and epidemic spread have become 
classified as an infectious disease. 
       This short list of features of AP treatment allows 
us to present the dominant views on the problem 
and principles of medical care in modern medicine on 
the eve of a pandemic. To this information, it is 
necessary to add such a fact as the indication of 
viruses along with bacteria among the most common 
pathogens of AP, which has been constantly 
published in the literature for many years. However, 
the significance of viruses was mainly declarative, 
since such observations were relatively rare, and 
special antiviral treatment had more trials than 
practical applications. 
But, on the other hand, the environment gave us 
clear signals about the approach of the viral era of 
inflammatory processes. The increase in the number 
of viral lung inflammations has become especially 
noticeable in the last couple of decades, which is 
quite consistent with long-term antibacterial 
therapeutic aggression and an increase in the share 
of viruses, as representatives of our microcosm, 
among the pathogens of AP. If we recall two fairly 
large coronavirus epidemics-SARS (2002-2004) and 
MERS (2012-2013), then it is not entirely correct to 
consider the pandemic as a complete surprise. To 
date, the similarity between the causative agents of 
these phenomena, which are designated as CoV, 
CoV-1 and CoV-2, respectively, has been proved [7]. 
Unfortunately, as the current situation shows, during 
the entire period after the first epidemic, no 
measures were developed or proposed that could 
help in the event of a repeat of the epidemic. 
       Now let's try to look at the sudden changes that 
are characteristic of the current coronavirus 
pandemic. First of all, the change in the 
epidemiological situation is an undoubted fact of 
novelty. The rapid spread of coronavirus in contact 
communication between people encourages the use 
of strict sanitary and quarantine measures and 
changes in the usual rhythm of life of entire 
countries. 
       Secondly, the most characteristic and severe 
lesion in coronavirus infection is pneumonia, which 
affects the same organ structures as the usual 
bacterial forms [1, 2]. The identity of morphological 
disorders generates the identity of functional shifts, 
so the descriptions of clinical signs of COVID-19 
pneumonia and bacterial forms of AP differ in 
nuances, but do not have significant differences. 
However, memorized ideas about the complete 
dependence of AP on the pathogen are the reason 
that coronavirus lung damage is considered as an 
independent specific type of pathology. 
       Third, practical medicine has lost the former 
importance of antibiotics, but the change in the 
etiological features of AP has not actually affected 
the stereotypical ideas about the principles of 
treatment. Attempts are being made to use drugs 
that have been approved to treat other viral 
infections, but the results of these efforts are not yet 
encouraging. Although the search for antiviral drugs 
continues, old antibiotic-based AP treatment 
regimens are still being used. For the current period, 
up to 70-80% of patients with coronavirus receive 
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antibiotics in the absence of direct indications for this 
and the previously known absence of an antiviral 
effect from their use [8-10]. 
       Fourthly, one of the main topics of discussion on 
how to help patients with coronavirus pneumonia 
today is devoted to methods of support when signs 
of respiratory failure appear. Such support usually 
begins with the supply of oxygen, which is not a 
therapeutic method in itself and serves only a 
palliative and replacement role, and methods are 
proposed that can slightly enhance the effect of 
oxygenation. For example, breathing oxygen in the 
prone positioning [11-14] or using a special cannula 
[15]. At the same time, it is recommended to 
carefully select the optimal time for intubation of the 
patient [16], and since the number of applicants for 
auxiliary ventilation has increased since the 
beginning of the pandemic, there are proposals to 
increase the production of necessary devices [17]. If 
we take into account the fact that this is the main 
effort of modern care for such patients, then this 
approach to the treatment of pneumonia should 
forget about the possibility of improving the final 
results. 
       Fifth, the materials of observations of large 
groups of people in the conditions of joint quarantine 
are very interesting and useful for forming new views 
on the problem [18, 19]. The data obtained showed 
that infection with coronavirus does not necessarily 
end with the disease. Up to 80% or more of those 
infected remain asymptomatic carriers, and among 
patients there is a wide range of clinical 
manifestations from barely noticeable signs to the 
development of terminal conditions. It should be 
emphasized that we are talking about infection with 
a single pathogen and the explanation of such clinical 
differences by special virulence will not be entirely 
correct. This phenomenon is not new, has long been 
known and has other explanations. 
       Finally, it is very interesting and even necessary 
to look at the information support of the current 
pandemic. Each of us, viewing daily news reports, 
unwittingly receives information about the number of 
infected, sick and dead from coronavirus infection. 
This information is constantly updated, and the 
replicated results leave a lasting impression with their 
scale. To date, the number of infected people in the 
world has already exceeded 44 million, and the 
number of deaths is approaching 1.2 million. 
       Such statistics are unusual and extreme even 
for many members of the medical profession and 
cause public concern, since each figure is the fate of 
a particular person. However, to understand the 
negative consequences of such information, it should 
be compared with statistics from similar and 
comparable situations. For example, just over a 
decade ago, there were about 450 million cases of 
AP per year worldwide, of which about 4 million were 
fatal [20, 21], and these figures have not changed 
significantly in subsequent years. Note that the 
overall figure reflects those who are sick, not 
infected, as in the current pandemic. Despite these 
truly tragic indicators, such statistics are little known 
even in medical circles, let alone in their daily 
coverage. 
       In this context, we are only talking about the 
medical aspects of the problem under discussion, so 
it is not entirely logical to be distracted by assessing 
the reasons for such a powerful attack on the 
formation of public opinion through the media. 
However, this fact in itself deserves a separate 
analysis of specialists working in this direction. 
       Understanding the specifics of modern medical 
care in COVID-19 allows us to at least outline the 
role of health systems in shaping treatment 
outcomes. The spread of infection depends primarily 
on the literacy and civic responsibility of the 
population, which in different parts of the world 
receives equivalent recommendations for strict 
sanitary and epidemiological measures, but the 
degree of compliance with these rules varies, which 
leads to the need for quarantine. Other methods of 
prevention have not yet been proposed by medicine, 
and vaccination of the population is still under 
development. It is likely that the number of infected 
people is significantly higher than recorded by 
statistics, since we are talking only about those who 
have been tested, and total verification is difficult to 
imagine even theoretically. 
       The fact that the vast majority of people 
infected with coronavirus do not get sick is a great 
gift of nature that is not directly related to any 
medical effort. Among patients with clinical 
symptoms of infection, most carry it relatively easily, 
despite the lack of specific effective care, especially 
since recognition of the ongoing search for such help 
can be found in almost every issue of specialized 
journals that discuss this topic. In this regard, it is 
illogical and incorrect to consider cured patients as 
the merit and success of medicine. This situation is 
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very accurately reflected in the expression that came 
from ancient times and attributed to Galen, that 
nature itself treats most of its patients, without 
requiring recognition and gratitude for its results. 
       Thus, if we evaluate real medical care during a 
pandemic, we should frankly admit that the majority 
of infected and sick people overcome this test thanks 
to the capabilities of their own body. The use of 
maintenance and replacement therapy begins in the 
late stages of the disease, when the patient's 
condition begins to deteriorate catastrophically, and 
the direction of such efforts does not have a radical 
effect on the dynamics of the process. The principles 
of such care in clinical situations close to terminal 
conditions can no longer make a decisive change in 
the course of the disease, so the mortality rate in 
intensive care units reaches 25-50% or higher [11, 
22, 23]. 
       Unlike patients who managed to survive viral 
aggression, most of the deceased are, in my opinion, 
on the conscience of medicine, which does not attach 
importance to timely and pathogenetically 
determined methods of treatment. Of course, among 
the dead there could be obviously hopeless 
observations, where the coronavirus complicated the 
course of concomitant serious diseases or affected 
people whose body, due to age regression, lost its 
former protective and compensatory capabilities. 
Such an assessment of known hopelessness can only 
be very conditional, since if the main mechanisms of 
the process were affected and the adaptation of the 
body was accelerated, the final result could be 
completely different, despite the aggravating factors. 
       The development of the section of pathogenetic 
care for AP is still hindered by the prevailing idea of 
the leading role of the pathogen and the importance 
of its suppression. This concept continues to rely on 
assumptions and analogies with other inflammatory 
processes, losing the unique differences between AP 
and diseases of other localization. At the same time, 
it is well known that a positive test for coronavirus 
does not mean the presence of pneumonia, the 
diagnosis of which is based only on the detection of a 
focus of inflammation in the lung. That is, the 
absolute sign of inflammation in the lungs is a lesion 
of the organ’s tissues, and not just the presence of a 
virus in the body, isn’t it?. 
       In turn, this focus affects the blood flow of the 
pulmonary circulatory system and only after that, as 
a result of the discrepancy between the self-
adaptation of the body and the speed of 
development of the process, there are synchronous 
violations of peripheral blood circulation. But it is 
generally accepted to monitor and correct circulatory 
disorders in AP by indicators of the periphery, not the 
lungs, right? If peripheral blood flow indicators are 
used for monitoring, it is necessary to take into 
account the fact that they have an inverse proportion 
to the pulmonary constants and are automatically 
regulated by the body. 
       The appearance of hypotension in AP is a sign 
of decompensation of circulatory shifts, as a result of 
the body's attempt to unload the pulmonary vessels, 
but in modern interpretation this signal is considered 
as a manifestation of septic shock, despite the 
absence of pathogens in the blood of the 
overwhelming number of such patients [24-26]. Now 
the same reason (septic shock in viral infection) 
explains such shifts in patients with COVID-19 [27]. 
This understanding of the mechanisms of the process 
in the lungs involves the inclusion of additional 
methods to increase peripheral pressure, instead of 
affecting its root causes. This misconception in 
assessing the causes and severity of the condition of 
patients plays, in my opinion, a fatal role in the fate 
of many of the dead. 
       This conclusion is based on the results of special 
studies with subsequent successful testing of 
pathogenetic treatment methods in the clinic. A 
detailed description of this work can be found in the 
recently published monograph [28].  
       Today, there is a wide discussion on the issue of 
COVID-19 on the pages of medical publications, in 
which opinions sometimes appear about a new 
strategy for solving this problem. Unfortunately, 
conversations about the novelty of the strategy are 
actually replaced by various tactical proposals that do 
not affect the main idea of the essence of the task. 
The main and only cause of the problem is 
considered to be the pathogen and its spread, and 
the main goal of its solution is ways to neutralize it. 
Such facts as the different degree of manifestation of 
the same type of coronavirus infection in different 
people, as well as the pathogenesis of severe and 
terminal conditions in it, remain without due 
attention. 
       One of the signs of a crisis in solving this 
problem is attempts to find and explain the reasons 
for medical failures by the incompetence of political 
leaders [29]. This statement indirectly indicates that 
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the authors are absolutely confident in the perfection 
of therapeutic efforts of modern medicine to help 
patients with CoV-2. According to the published text, 
it turns out that the cause of death of patients with 
coronavirus is state policy, and not any defects in the 
provision of medical care (see above). In this regard, 
it would be interesting to know why there is no direct 
correlation between the number of people infected 
with coronavirus, the percentage of deaths, and the 
political spectrum of different countries. It is a pity 
that the editorial Board of a prestigious journal, 
which should now be a leader in finding effective 
solutions to this problem, has taken such an 
unproductive position with the transfer of discussion 
of urgent medical problems to completely 
unprofessional ground. 
       Current statistics of the pandemic indicate that 
the spread of coronavirus is quite aggressive and 
fast, slowing down, but not stopping, even in 
conditions of quarantine and compliance with 
sanitary and anti-epidemic measures. At the same 
time, the rate of morbidity and mortality among 
infected people is relatively low, compared to many 
dangerous infections, which does not fit into the 
previously expressed suspicions about COVID-19 as a 
biological weapon. In addition, the appearance of 
information about the lack of stable and long-term 
immunity in patients who have had COVID-19, as 
well as cases of repeated diseases, is an indirect sign 
that the expected vaccination may not fully achieve 
its goal and that this infection may continue its 
further movement. 
       At the moment, all eyes are on the developers 
of vaccines and antiviral drugs, the creation and use 
of which is expected to be a major turning point in 
the fight against coronavirus. However, these 
expectations are based on plans and assumptions, 
the timing and success of which is still difficult to 
predict. At the same time, there is a group of 
patients who are in urgent need of not only 
supportive, but also pathogenetic treatment. Will 
these patients timely and effective assistance, 
depends not so much on the practitioners of 
medicine who strictly follow established guidelines 
and operate within acceptable regimens, but from 
professionals, influencing the formation of ideologies 
and ways of solving problems in modern health 
systems. 
       The near future will show us whether there are 
progressive leaders among modern medical 
specialists who can bring the system of views on the 
nature of AP in line with the fundamental provisions 
of medical science and determine a set of treatment 
methods that can influence the mechanisms of 
disease development, and not only the factors that 
contribute to its occurrence. Only then will real 
conditions be created for effective care of patients 
with inflammation of the lung tissue, most of whom 
will be able to avoid critical situations. 
 
Conclusion 
 Real emergency care for patients with 
coronavirus infection is necessary and quite 
achievable today, since it is based on methods of 
adapting the body to new conditions and has its own 
fundamental scientific justification. Etiotropic 
treatment, even in the presence of such drugs, when 
the first signs of decompensation of the process 
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